Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 17, Issue 3, 1999, Pages 313-320

  Angelis Stoforidis, P ^b   Vajda, F J E ^a   Christophidis, N ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE

Author keywords

Clinical efficacy; Erythrocytes; Methotrexate polyglutamates; Polymorphs; Rheumatoid arthritis

Indexed keywords

DICLOFENAC; FOLIC ACID; HYDROXYCHLOROQUINE; IBUPROFEN; KETOPROFEN; METHOTREXATE; NAPROXEN; PIROXICAM; POLYGLUTAMIC ACID; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESPONSE; ERYTHROCYTE; FEMALE; HAIR LOSS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MOUTH ULCER; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD CELLS; CELL SEPARATION; DRUG THERAPY, COMBINATION; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; LINEAR MODELS; MALE; METHOTREXATE; MIDDLE AGED; POLYGLUTAMIC ACID;

EID: 0033023168     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. WEINBLATT ME: Methotrexate for chronic diseases in adults. N Engl J Med 1995; 332: 330-1.
2. WEJNBLATT ME, COBLYN JS, FOX DA et al.: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818-22.
3. Methoblastin. In THOMAS J (Ed.): Australian Prescription Products Guide. Hawthorn, Vic., Australian Pharmaceutical Publishing Company Limited, 1998: 1770-4.
4. CHRISTOPHIDIS N: Methotrexate. Clin Rheum Dis 1984; 10: 401-15.
5. ChRISTOPHIDIS N, DAWSON TM, ANGELIS P, RYAN PFJ: Effect of age on methotrexate clearance in patients with rheumatoid arthritis. Aust NZ J Med 1994; 24: 422.
6. PINKERTON CR, WELSHMAN SG, GLASGOW JFT, BRIDGES JM: Can food influence the absorption of methotrexate in children with acute lymphoblastic leukemia? Lancet 1980; II: 944-6.
7. COSOLO W, DRUMMER OH, CHRISTOPHIDIS N: Comparison of high-performance liquid chromatography and the Abbott Fluorescent Polarization Radioimmunoassay in the measurement of methotrexate. J Chromatogr 1989; 494: 201-8.
8. KREMER JM: The mechanism of action of methotrexate in rheumatoid arthritis: The search continues. J Rheumatol 1994; 21: 1-5.
9. HENDEL J, NYFORS A: Pharmacokinetics of methotrexate in erythrocytes in psoriasis. Eur J Clin Pharmacol 1984; 27: 607-10.
10. SCHRODER H: In vivo methotrexate kinetics and metabolism in human hematopoietic cells. Dan Med Bull 1990; 37: 22-40.
11. BAUGH CM, KRUMDIECK CL, NAIR MG: Polygammaglutamyl metabolites of methotrexate. Biochem Biophys Res Commun 1973; 52: 27-34.
12. 10-methylpteroylglutamyl-γ-glutamate. Biochem Biophys Res Commun 1975; 63: 692-8.
13. SCHALHORN A, SAUER H, WILMANNS W, STUPP-POUTOT G: Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate. Cancer Chemother Pharmacol 1982; 9: 65-9.
14. SCHRODER H: Methotrexate pharmacokinetics in age-fractionated erythrocytes. Cancer Chemother Pharmacol 1986; 18: 203-7.
15. SCHRODER H, CLAUSEN N, OSTERGAARD E, PRESSLER T: Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment. Cancer Chemother Pharmacol 1986; 16: 190-193.
16. SCHRODER H: Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils. Cancer Chemother Pharmacol 1987; 19: 42-6.
17. CRONKITE EP: Kinetics of granulocytopoiesis. Clin Haematol 1979; 8: 351-70.
18. WHITEHEAD VM, ROSENBLATT DS, VUCHICH MJ, SHUSTER JJ, WITTE A, BEAULIEU D: Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: A pilot prognostic factor analysis. Blood 1990; 76: 44-9.
19. SCHMIEGELOW K, SCHRODER H, GUSTAFSSON G et al.: Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology. J Clin Oncol 1995; 13: 345-51.
20. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
21. IMBERT AM, PIGNON T, LENA N: Enzymatic assay for methotrexate with a centrifugal analyzer (Cobas-bio). Clin Chem 1983;29:1317-8.
22. SCHRODER H, HEINSVIG EM: Enzymatic assay for MTX in erythrocytes. Scand J Clin Lab Invest 1985; 45: 657-9.
23. SCHRODER H: Methotrexate in neutrophils in children with acute lymphoblastic leukaemia. Cancer Chemother Pharmacol 1987; 19: 339-42.
24. KILLMANN SA, CRONKITE EP, FLIEDNER TM, BOND VP: Mitotic indices of human bone marrow cells. III. Duration of some phases of erythrocytic and granulocytic proliferation computed from mitotic indices. Blood 1964; 24: 267-80.
25. DA COSTA M, IQBAL MP: The transport and accumulation of methotrexate in human erythrocytes. Cancer 1981; 48: 2427-32.
26. SCHMIEGELOW K, SCHRODER H, PULCZYNSKA MK, HEJL M: Maintenance chemotherapy for childhood acute lymphoblastic leukemia: Relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes. Cancer Chemother Pharmacol 1989; 25: 65-9.
27. SCHRODER H, FOGH K: Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 1988; 21: 145-9.
28. ROSENBLATT DS, WHITEHEAD VM, VERA N, POTTIER A, DUPONT M, VUCHICH M-J: Prolonged inhibition of DNA synthesis associated with the accumulation of methotrexate polyglutamates by cultured human cells. Mol Pharmacol 1978; 14: 1143-7.
29. GALIVAN J: Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate. Mol Pharmacol 1980; 17: 105-10.
30. FRY DW, YALOWICH JC, GOLDMAN ID: Rapid formation of poly-γ-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high-pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J Biol Chem 1982; 257: 1890-6.
31. 5 to dihydrofolate reductase. J Clin Invest 1983; 72: 773-8.
32. ALLEGRA CJ, CHABNER BA, DRAKE JC, LUTZ R, RODBARD D, JOLIVET J: Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. J Biol Chem 1985; 260: 9720-9726.
33. ALLEGRA CJ, DRAKE JC, JOLIVET J, CHABNER BA: Inhibition of phosphoribosyl-amino-imidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc Natl Acad Sci USA 1985; 82: 4881-5.
34. BAGGOTT JE, VAUGHN WH, HUDSON BB: Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidised folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J 1986; 236: 193-200.
35. CRONSTEIN BN: Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996; 39: 1951-60.
36. BAGGOTT JE, MORGAN SL, KOOPMAN WJ: The effect of methotrexate and 7-hydroxymethotrexate on rat adjuvant arthritis and on urinary aminoimidazole carboxamide excretion. Arthritis Rheum 1998; 41: 1407-10.
37. CRONSTEIN BN, EBERLE MA, GRUBER HE, LEVIN RI: Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991; 88: 2441-5.